Hepatobiliary Surgery Practice Questions

Q: In which stage of gallbladder carcinoma is liver lobe resection considered for patients with carcinoma of the gallbladder?

Stage IIA. **Explanation:** The management of gallbladder carcinoma (GBC) is primarily determined by the depth of wall invasion (T-stage). **Why Stage IIA is Correct:** Stage IIA (T2a N0 M0) involves tumor invasion into the **perimuscular connective tissue on the peritoneal side**, without involvement of the serosa. For T2 tumors, a simple cholecystectomy is oncologically inadequate due to the high risk of lymphatic spread and micrometastasis. Therefore, **Radical (Extended) Cholecystectomy** is the standard of care. This procedure includes: 1. Removal of the gallbladder. 2. **Wedge resection of the liver (Segments IVb and V)** or a formal liver lobe resection to ensure negative margins (R0 resection). 3. Regional lymphadenectomy (portal lymph nodes). **Analysis of Incorrect Options:** * **Stage IA (T1a N0 M0):** The tumor is limited to the lamina propria. A **simple cholecystectomy** is curative with excellent 5-year survival rates; liver resection is unnecessary. * **Stage III:** This represents advanced local disease (T3) or regional lymph node involvement (N1). While surgery may still be attempted, it often requires more extensive multivisceral resections, and the prognosis is significantly poorer. * **Stage IV:** This stage indicates distant metastasis (M1) or extensive vascular/nodal involvement. These cases are generally considered **unresectable**, and management is palliative. **High-Yield Clinical Pearls for NEET-PG:** * **Most common histological type:** Adenocarcinoma. * **Most common site of spread:** Liver (direct invasion). * **Incidental GBC:** If T1a is found after simple cholecystectomy, no further surgery is needed. If T1b or higher is found, a completion radical cholecystectomy is required. * **Nevin’s Staging and TNM Staging** are both used, but TNM is the current gold standard for surgical planning.

Q: Black bile stones are composed of which of the following?

Calcium bilirubinate stones. **Explanation:** Gallstones are broadly classified into **Cholesterol stones** and **Pigment stones**. Pigment stones are further subdivided into **Black** and **Brown** stones. **1. Why Option A is Correct:** Black pigment stones are primarily composed of **Calcium Bilirubinate** (insoluble polymers of unconjugated bilirubin) mixed with calcium phosphates and carbonates. They form in the gallbladder when there is an excess of unconjugated bilirubin in the bile. This typically occurs in states of **chronic hemolysis** (e.g., Hereditary Spherocytosis, Sickle Cell Anemia, Thalassemia) or **Cirrhosis**. Unlike brown stones, black stones are usually sterile and form in the absence of infection. **2. Why the other options are incorrect:** * **Option B:** Cholesterol monohydrate is the primary component of **Cholesterol stones** (the most common type in the West), formed due to bile supersaturation with cholesterol. * **Option C:** Calcium monohydrate is not a standard constituent of gallstones; calcium in stones is usually present as bilirubinate, carbonate, or phosphate. * **Option D:** While pigment stones contain some cholesterol, "Cholesterol bilirubinate" is not a recognized medical classification for black stones. **High-Yield Clinical Pearls for NEET-PG:** * **Radiopacity:** Black stones are often **radiopaque** (50-75% visible on X-ray) due to high calcium content, whereas cholesterol stones are typically radiolucent. * **Brown Stones:** Composed of calcium bilirubinate and **calcium palmitate/stearate**. They are associated with **biliary stasis and infection** (e.g., *E. coli*, *Clonorchis sinensis*) and usually form in the bile ducts. * **Risk Factors for Black Stones:** The "Hemolysis-Cirrhosis" dyad. * **Risk Factors for Cholesterol Stones:** The "5 F's" (Fat, Female, Fertile, Forty, Fair).

Q: Following resection of two-thirds of the liver, regeneration is complete within approximately what time frame?

4-6 months. **Explanation:** The liver possesses a unique and remarkable capacity for compensatory hyperplasia. Following a major resection (such as a 75% hepatectomy), the remaining hepatocytes exit the quiescent $G_0$ phase and enter the cell cycle to restore the original functional liver mass. **1. Why 4-6 months is correct:** While the initial surge of cellular proliferation begins within hours and the majority of the liver volume is restored relatively quickly (often within weeks), the complete structural reorganization, functional maturation, and stabilization of the liver mass to its pre-resection state typically take **4 to 6 months**. This timeframe accounts for the full restoration of the complex lobular architecture and metabolic capacity. **2. Analysis of Incorrect Options:** * **4-5 weeks (Option D):** This is the period where the most rapid increase in liver volume occurs, but the regeneration process is not yet "complete" in terms of functional maturity. * **8-10 weeks / 2-3 months (Options B & A):** While significant progress is made by this stage, these durations underestimate the time required for the final remodeling phase of the biliary tree and vascular supply. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Liver regeneration is **compensatory hyperplasia**, not true regeneration (the lost lobes do not regrow; instead, the remaining lobes enlarge). * **Key Mediators:** Hepatocyte Growth Factor (HGF) and Transforming Growth Factor-alpha (TGF-$\alpha$) are the primary stimulators. * **Inhibitor:** Transforming Growth Factor-beta (TGF-$\beta$) acts as a potent inhibitor to stop the process once the mass is restored. * **Limit of Resection:** In a healthy liver, up to **75-80%** can be safely resected. In a cirrhotic liver, this limit is significantly lower (usually <40%) due to impaired regenerative capacity.

Q: Prognosis of a retroperitoneal (poocaval) shunt depends on which of the following factors?

Type of shunt created. **Explanation:** The prognosis and physiological outcome of a portosystemic shunt are primarily determined by the **Type of shunt created**. Shunts are classified into three categories based on their hemodynamic impact: 1. **Total Shunts (e.g., End-to-side Portocaval):** These divert all portal blood flow away from the liver. While they are most effective at preventing re-bleeding, they carry the highest risk of hepatic encephalopathy and liver failure because the liver is deprived of hepatotrophic portal factors. 2. **Partial Shunts (e.g., Small-diameter interposition grafts):** These lower portal pressure while maintaining some prograde (hepatopetal) flow, balancing bleeding control with a lower risk of encephalopathy. 3. **Selective Shunts (e.g., Distal Splenorenal/Warren Shunt):** These decompress gastroesophageal varices while maintaining portal hypertension and flow to the liver, offering the best long-term metabolic prognosis. **Why other options are incorrect:** * **Serum Bilirubin, Albumin, and Ascites (Options A, B, C):** These are components of the **Child-Pugh Score**. While they help determine the *pre-operative* risk and the patient's suitability for surgery (surgical fitness), they do not define the specific prognostic outcome of the shunt procedure itself. The hemodynamic design of the shunt (Type) is the definitive factor in post-operative complications like encephalopathy. **Clinical Pearls for NEET-PG:** * **Gold Standard for Variceal Bleeding:** Endoscopic Variceal Ligation (EVL). * **Distal Splenorenal Shunt (DSRS):** The procedure of choice for elective decompression in patients with preserved liver function; it is "selective" and avoids the liver. * **TIPS (Transjugular Intrahepatic Portosystemic Shunt):** Acts as a side-to-side (total) shunt; it is the preferred "bridge" to transplant. * **Child-Pugh Class C:** Generally a contraindication for elective portosystemic shunt surgery due to high mortality.

Q: A patient operated for colonic carcinoma develops a solitary nodule in the liver. What is the treatment of choice?

Surgery. **Explanation:** The liver is the most common site for distant metastasis in colorectal cancer (CRC) due to portal venous drainage. In the case of a **solitary liver metastasis** (or even limited resectable lesions), **Surgery (Hepatic Resection)** is the treatment of choice because it offers the only potential for long-term survival and cure. * **Why Surgery is Correct:** Unlike many other cancers where liver metastasis signifies terminal stage IV disease, colorectal liver metastases (CRLM) are unique. If the primary tumor is controlled and the liver lesion is resectable with adequate future liver remnant (FLR), surgery can achieve a 5-year survival rate of 30-50%. * **Why Other Options are Incorrect:** * **Radiation:** The liver has low tolerance for whole-organ radiation (risk of radiation-induced liver disease). While SBRT is an option for non-surgical candidates, it is not the "treatment of choice" for a fit patient with a resectable solitary nodule. * **Chemotherapy:** While often used as neoadjuvant or adjuvant therapy, chemotherapy alone is palliative and cannot achieve the curative rates offered by surgical resection. * **Conservative Treatment:** This is inappropriate for a potentially curable stage of metastatic disease. **Clinical Pearls for NEET-PG:** * **Resectability Criteria:** Based on whether the tumor can be completely removed (R0 resection) while leaving at least 25-30% of healthy liver tissue. * **Carcinoembryonic Antigen (CEA):** The most important tumor marker for monitoring recurrence in post-op colonic carcinoma patients. * **Synchronous vs. Metachronous:** If the liver nodule is found at the same time as the primary, it is "synchronous"; if found later, it is "metachronous." Surgery remains the gold standard for both if resectable.

Q: Which of the following is a tumor marker for hepatocellular carcinoma (HCC)?

Alpha-fetoprotein (AFP). **Explanation:** **Alpha-fetoprotein (AFP)** is the most widely used and established serum tumor marker for **Hepatocellular Carcinoma (HCC)**. It is a glycoprotein normally produced by the fetal yolk sac and liver. In adults, pathological elevation (typically >400 ng/mL) in the setting of chronic liver disease or cirrhosis is highly suggestive of HCC. However, it is important to note that AFP can also be elevated in germ cell tumors (yolk sac tumors) and during liver regeneration (chronic hepatitis). **Analysis of Options:** * **Alpha-fucosidase (AFU):** While AFU is a lysosomal enzyme that can be elevated in HCC patients, it is considered an *adjunct* marker rather than the primary diagnostic standard. It lacks the specificity and widespread clinical validation of AFP. * **Des-gamma-carboxyprothrombin (DCP/PIVKA-II):** This is an abnormal prothrombin molecule produced by HCC cells. While it is a highly specific marker for HCC and often used in combination with AFP to increase sensitivity, it is not the "classic" or primary answer expected in standard examinations unless specified as a complementary marker. * **CA 19-9:** This is the primary tumor marker for **Cholangiocarcinoma** and pancreatic adenocarcinoma. It is not specific for HCC. **High-Yield Clinical Pearls for NEET-PG:** * **Screening Protocol:** For high-risk patients (cirrhotics), the standard screening involves **USG Abdomen + Serum AFP** every 6 months. * **Diagnostic Threshold:** An AFP level >400 ng/mL in a patient with a hypervascular liver mass on Triphasic CT is often diagnostic. * **Fibrolamellar Variant:** This specific subtype of HCC (seen in young non-cirrhotics) typically has **normal AFP levels** but elevated Neurotensin. * **Other Markers:** Glypican-3 (GPC3) is a newer immunohistochemical marker used to differentiate HCC from benign nodules.

Q: What is the most common cause of biliary stricture?

Trauma. **Explanation:** The most common cause of biliary stricture is **iatrogenic trauma**, specifically injuries occurring during surgical procedures. **1. Why Trauma is Correct:** Approximately **80% of all benign biliary strictures** result from operative trauma. The most frequent culprit is **laparoscopic cholecystectomy**, where the common bile duct (CBD) may be inadvertently clipped, ligated, or transected due to anatomical variations or inflammation. Other traumatic causes include injuries during gastric resections, pancreatic surgeries, or liver transplantations. Ischemic injury to the bile duct (which relies on a tenuous blood supply at the 3 and 9 o'clock positions) also leads to post-surgical fibrosis and stricture formation. **2. Why Other Options are Incorrect:** * **Common bile duct stone:** While stones cause biliary *obstruction*, they rarely cause a permanent fibrous *stricture* unless they lead to chronic recurrent cholangitis or Mirizzi syndrome. * **Asiatic cholangitis (Recurrent Pyogenic Cholangitis):** This is a common cause of strictures in specific geographic regions (Southeast Asia) due to parasitic infections (e.g., *Clonorchis sinensis*), but it is not the most common cause globally or in general surgical practice. * **Congenital anomaly:** Conditions like biliary atresia or choledochal cysts cause neonatal or pediatric biliary issues but are far less common than acquired traumatic strictures in the general population. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Investigation:** MRCP (Magnetic Resonance Cholangiopancreatography) is the initial investigation of choice to define the anatomy. * **Management:** Minor leaks/strictures may be managed via ERCP with stenting. Major transections usually require a **Roux-en-Y Hepaticojejunostomy**. * **Bismuth Classification:** Used to grade the level of biliary stricture based on the distance from the hilar confluence.

Question 1

In which stage of gallbladder carcinoma is liver lobe resection considered for patients with carcinoma of the gallbladder?

Accepted Answer

Stage IIA

Answer

Stage IA

Answer

Stage III

Answer

Stage IV

Question 2

A patient with an 8 cm x 8 cm abscess in the right lobe of the liver was treated with multiple aspirations (3 times) and systemic amebicides. A cavity remains in the right lobe of the liver, but it is now empty. A seven-day course of luminal amebicides has been administered. How will you follow up?

Accepted Answer

Ultrasound (USG) weekly for 1 month, followed by monthly USG until 1 year

Answer

Stool examination only

Answer

Ultrasound (USG) weekly for 3 months, followed by CT scan at 3 months

Answer

Ultrasound (USG) or CT scan monthly and stool examination weekly

Question 3

Black bile stones are composed of which of the following?

Accepted Answer

Calcium bilirubinate stones

Answer

Cholesterol monohydrate stones

Answer

Calcium monohydrate stones

Answer

Cholesterol bilirubinate stones

Question 4

Following resection of two-thirds of the liver, regeneration is complete within approximately what time frame?

Accepted Answer

4-6 months

Answer

2-3 months

Answer

8-10 weeks

Answer

4-5 weeks

Question 5

Which surgical operation precipitates portosystemic encephalopathy?

Accepted Answer

Portacaval anastomosis

Answer

Splenorenal shunt

Answer

Sugiura operation

Answer

Talma-Morison operation

Question 6

An otherwise normal female presents with symptoms of flatulent dyspepsia. She was started on proton pump inhibitors, which controlled her symptoms. What is the next step in the management of this condition?

Accepted Answer

Wait and watch

Answer

Immediate laparoscopic cholecystectomy

Answer

Laparotomy after 1 or 2 months

Answer

Endoscopic retrograde cholangiopancreatography

Question 7

Prognosis of a retroperitoneal (poocaval) shunt depends on which of the following factors?

Accepted Answer

Type of shunt created

Answer

Serum bilirubin level

Answer

Serum albumin level

Answer

Presence of refractory ascites

Question 8

A patient operated for colonic carcinoma develops a solitary nodule in the liver. What is the treatment of choice?

Accepted Answer

Surgery

Answer

Radiation

Answer

Chemotherapy

Answer

Conservative treatment

Question 9

Which of the following is a tumor marker for hepatocellular carcinoma (HCC)?

Accepted Answer

Alpha-fetoprotein (AFP)

Answer

Alpha fucosidases

Answer

Des-gamma-carboxyprothrombin (DCGP)

Answer

Carbohydrate antigen 19-9 (CA 19-9)

Question 10

What is the most common cause of biliary stricture?

Accepted Answer

Trauma

Answer

Common bile duct stone

Answer

Asiatic cholangitis

Answer

Congenital anomaly

Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?